Zhongchao Inc. (ZCMD): Price and Financial Metrics


Zhongchao Inc. (ZCMD): $1.73

0.06 (+3.59%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ZCMD POWR Grades


  • Value is the dimension where ZCMD ranks best; there it ranks ahead of 82.58% of US stocks.
  • ZCMD's strongest trending metric is Momentum; it's been moving down over the last 33 weeks.
  • ZCMD ranks lowest in Growth; there it ranks in the 21st percentile.

ZCMD Stock Summary

  • ZCMD's went public 1.65 years ago, making it older than merely 2.26% of listed US stocks we're tracking.
  • For ZCMD, its debt to operating expenses ratio is greater than that reported by merely 5.5% of US equities we're observing.
  • With a year-over-year growth in debt of -91.45%, Zhongchao Inc's debt growth rate surpasses only 2.55% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Zhongchao Inc are BRC, JOUT, IOSP, ISDR, and MLHR.
  • ZCMD's SEC filings can be seen here. And to visit Zhongchao Inc's official web site, go to www.izcmd.com.

ZCMD Valuation Summary

  • ZCMD's price/sales ratio is 2.5; this is 52.83% lower than that of the median Technology stock.
  • ZCMD's EV/EBIT ratio has moved down 20.6 over the prior 18 months.
  • ZCMD's price/sales ratio has moved down 5.3 over the prior 18 months.

Below are key valuation metrics over time for ZCMD.

Stock Date P/S P/B P/E EV/EBIT
ZCMD 2021-09-01 2.5 1.4 10.0 5.9
ZCMD 2021-08-31 2.5 1.4 10.1 6.0
ZCMD 2021-08-30 2.5 1.4 10.0 5.9
ZCMD 2021-08-27 2.5 1.4 10.0 5.9
ZCMD 2021-08-26 2.5 1.4 9.9 5.9
ZCMD 2021-08-25 2.5 1.4 10.0 5.9

ZCMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ZCMD has a Quality Grade of C, ranking ahead of 45.59% of graded US stocks.
  • ZCMD's asset turnover comes in at 0.685 -- ranking 24th of 51 Personal Services stocks.
  • 500 - Internal server error

The table below shows ZCMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 0.685 0.660 0.409
2020-12-31 0.685 0.660 0.409
2019-12-31 0.937 0.687 0.772

ZCMD Stock Price Chart Interactive Chart >

Price chart for ZCMD

ZCMD Price/Volume Stats

Current price $1.73 52-week high $4.09
Prev. close $1.67 52-week low $1.46
Day low $1.68 Volume 16,400
Day high $1.74 Avg. volume 988,364
50-day MA $1.64 Dividend yield N/A
200-day MA $1.80 Market Cap 31.29M

Zhongchao Inc. (ZCMD) Company Bio


Zhongchao, Inc. is a holding company that engages in the provision of healthcare information, education, and training services. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference & workshops, continuing education courses, articles & short videos with educational healthcare content to healthcare professionals as well as the public. The company was founded by Wei Guang Yang on April 16, 2019 and is headquartered in Shanghai, China.


ZCMD Latest News Stream


Event/Time News Detail
Loading, please wait...

ZCMD Latest Social Stream


Loading social stream, please wait...

View Full ZCMD Social Stream

Latest ZCMD News From Around the Web

Below are the latest news stories about Zhongchao Inc that investors may wish to consider to help them evaluate ZCMD as an investment opportunity.

Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced the launch of its multidisciplinary treatment ("MDT") clinical thinking training platform for hematology ("Hematology MDT Platform"). The Hematology MDT Platform provides clinicians with a channel to learn multidisciplin

Yahoo | September 17, 2021

Can Zhongchao Inc. (NASDAQ:ZCMD) Maintain Its Strong Returns?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Yahoo | September 14, 2021

Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") launches Hematological Tumor Patient Care Center (the "Care Center"), continuing to improve its business ecology in tumor patient management and

Yahoo | September 10, 2021

Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management platform, today announced its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") provides patient follow-up management services for ovarian cancer patients from Zeyoulexiang Patient Assistance Project (the "Project"), helping

Yahoo | August 25, 2021

Zhongchao Inc. Builds A Patient DOT Management System

Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that its subsidiary Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin") launches Treatment Outcome Oriented DOT Management System ("DOT Management System") to accelerate the development of patient management business, meeting the increasing demand in tumor and rare disease pa

Yahoo | August 12, 2021

Read More 'ZCMD' Stories Here

ZCMD Price Returns

1-mo 10.90%
3-mo 4.22%
6-mo -4.31%
1-year -6.99%
3-year N/A
5-year N/A
YTD 1.76%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8465 seconds.